Japanese Food Stock News

If you are wondering whether Kajima’s share price still offers value after a strong run, you are not alone. This article is designed to help you weigh what you are really paying for. Kajima’s stock last closed at ¥7,142, with returns of 0.8% over 7 days, 12.1% over 30 days, 18.8% year to date, 136.6% over 1 year and a very large gain over 5 years based on these figures. Recent coverage has focused on Kajima’s role as a major Japanese construction and civil engineering group, including...

Leadership changes at Mizuho Financial Group Mizuho Financial Group (TSE:8411) has announced a major boardroom reshuffle, with Hidekatsu Take set to become Chairperson and Masayuki Sugawara stepping into the Deputy President & Corporate Executive role from April 1, 2026. See our latest analysis for Mizuho Financial Group. The leadership reshuffle comes after a strong run in the shares, with a 30.66% 90 day share price return and a 21.74% year to date share price return. The 5 year total...

Why SMS Holdings’ FY2025 Results Matter for Systena (TSE:2317) SMS Holdings’ FY2025 results, featuring solid overall financial footing supported by non-operating income despite an operating loss, are drawing attention because the unlisted parent owns 29% of Systena and shares leadership. For you as a Systena shareholder, that disclosure provides additional context about the financial resources and stability of the largest controlling investor. This can influence confidence in group-wide...

Nidec (TSE:6594) is back in focus after founder Shigenobu Nagamori stepped down as Chairman Emeritus during a third party accounting probe, alongside a Q3 earnings beat and an upgraded profitability outlook. See our latest analysis for Nidec. Those governance changes and the Q3 earnings beat have arrived alongside a 90 day share price return of 25.04% and a year to date share price return of 17.69%. However, the 1 year total shareholder return of a 7.60% decline and the 5 year total...

Mitsubishi Motors (TSE:7211) has appointed Kyoya Igarashi as Representative Executive Officer, Executive Vice President (Sales). The appointment is scheduled to take effect on April 1, 2026. The new role gives Igarashi responsibility for the company’s global sales leadership. Mitsubishi Motors, listed on the Tokyo Stock Exchange under ticker TSE:7211, focuses on automotive manufacturing and sales across multiple regions. A change at the top of the sales organization can influence how the...

Kubota (TSE:6326) is back on investors’ radar after a recent upgrade to a top analyst rating, driven by steadily higher earnings estimates that place it among the strongest positive revision stories. See our latest analysis for Kubota. The recent upgrade comes as Kubota’s 1 month share price return of 38.21% and year to date share price return of 41.66% build on a 1 year total shareholder return of 76.32%. Together, these figures point to clearly strengthening momentum around the ¥3,176 share...

Mitsubishi HC Capital recently completed and announced multiple unsecured fixed-rate bond offerings totaling ¥45 billion-equivalent across yen and Korean won, alongside approving extensive leadership changes effective April 1, 2026. The combination of diversified long-term funding in different currencies and a refreshed senior management lineup signals an emphasis on balance sheet flexibility and governance focus. Next, we will examine how this push into longer-dated fixed-income funding...

Share buyback announcement and what it could mean for you Ogaki Kyoritsu Bank (TSE:8361) has announced a share repurchase program of up to 5,550,000 shares, or 1.32% of its issued share capital, with a budget of ¥4,000 million running through March 31, 2026. See our latest analysis for Ogaki Kyoritsu Bank. The buyback news follows a strong run in the shares, with a 30-day share price return of 21.28%, a 90-day return of 62.28%, and a 1-year total shareholder return of 223.12%. This suggests...

Recent performance snapshot and why Astellas is on investors' radar Astellas Pharma (TSE:4503) has attracted fresh attention after a strong run in its shares over the past month and past 3 months, prompting investors to reassess how the stock is currently priced. See our latest analysis for Astellas Pharma. At a share price of ¥2,601.5, Astellas Pharma’s recent momentum is strong, with a 30 day share price return of 22.02% and a 90 day share price return of 32.12%. Its 1 year total...

IHI Corporation is considering an absorption-type merger with its consolidated subsidiary, IHI Segment Corporation. The plan is currently under review by the board, signaling a potential change in the group’s internal structure. The move is aimed at closer business integration and potential efficiency gains within the IHI group. IHI, traded as TSE:7013, is drawing fresh attention as the board weighs a merger with IHI Segment Corporation on top of an already strong share price at ¥4,303.0...

If you are asking whether Tokyo Electron is still worth considering at today’s price, you are in the right place. This article will focus on what the current share price implies about the company’s value. The stock last closed at ¥44,010, with returns of 0.1% over the past 7 days, 0.5% over 30 days, 19.2% year to date, 103.9% over 1 year and 199.4% over 3 years, so many holders are now wondering what is already priced in. Recent headlines around Tokyo Electron have mainly centred on its role...

Stock hits 52-week high as investors focus on demand and dividends Nihon Yamamura Glass (TSE:5210) hit a new 52-week high on strong volume, as interest in its packaging products and clearer expectations for future dividends drew investors in ahead of the May earnings date. See our latest analysis for Nihon Yamamura Glass. The fresh 52 week high builds on solid momentum, with a 30 day share price return of 12.76% and a 90 day gain of 23.23%, alongside a very large 3 year total shareholder...

Invincible Investment (TSE:8963) just posted its FY 2025 results with second half revenue of ¥28.6b and basic EPS of ¥2,182.45, while the trailing twelve months show revenue at ¥53.7b and basic EPS at ¥4,061.28. Over recent periods, revenue has moved from ¥25.6b in FY 2024 H2 to ¥25.1b in FY 2025 H1 and then to ¥28.6b in FY 2025 H2, with EPS shifting from ¥1,980.36 to ¥1,878.83 and then to ¥2,182.45. This sets up a picture where investors will be weighing how durable these margins look...

Gunma Bank (TSE:8334) has called a board meeting for 25 February 2026 to consider changes in representative directors and other officers, putting potential leadership shifts on the radar for shareholders. See our latest analysis for Gunma Bank. The leadership agenda comes on the back of a strong run in the shares, with a 1 month share price return of 18.83% and a 1 year total shareholder return above 100%, pointing to momentum that has been building rather than fading. If this kind of...

If you are wondering whether Suzuki Motor's current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. The stock last closed at ¥2,370.5, with returns of 3.3% over the past week, 15.2% over the past month, a 0.9% decline year to date, and 32.9% over the past year. It has also delivered very large multi year returns of 106.1% over three years and 123.1% over five years. Recent news around Suzuki Motor has focused on its...

Olympus (TSE:7733) recently guided for a full year dividend of ¥30.00 per share for the year ending March 31, 2026, compared with ¥20.00 a year earlier and drawing fresh attention to the stock. See our latest analysis for Olympus. The dividend guidance comes after a challenging period for holders, with a 1 day share price return of 2.55% and a 7 day return of 3.24%, set against a 30 day share price decline of 16.07% and a 1 year total shareholder return of 24.61%. If this update has you...

Why ELEVIDYS matters for Chugai Pharmaceutical (TSE:4519) Chugai Pharmaceutical (TSE:4519) has just launched ELEVIDYS in Japan as the first gene therapy for Duchenne muscular dystrophy, following its listing on the National Health Insurance price list. This product milestone expands Chugai’s rare disease gene therapy offering and introduces a new treatment option for eligible DMD patients, supported by data from the global Phase 3 EMBARK study. See our latest analysis for Chugai...

Why DAIHEN (TSE:6622) is on investors’ radar today Recent share price moves in DAIHEN (TSE:6622), including a month return of 24.8% and a past 3 months return of 67.4%, have drawn attention to how the market is currently pricing the business. See our latest analysis for DAIHEN. That recent 30 day share price return of 24.8%, alongside a 36.96% year to date share price gain and a 116.69% 1 year total shareholder return, points to building momentum as investors reassess DAIHEN’s growth...

GMO Internet Group, Inc. has resolved to seek shareholder approval on March 19, 2026, to amend its Articles of Incorporation and, following the Annual General Shareholders Meeting, will see Independent Director and Audit and Supervisory Committee Member Keigo Ogura retire at the end of his term. The planned expansion of the company’s corporate purposes into AI, robotics, cybersecurity, and insurance signals a broader business scope beyond its traditional internet infrastructure focus. We’ll...

Why NTT (TSE:9432) Is On Investors’ Radar Today NTT (TSE:9432) has drawn fresh attention after recent share price moves, with the stock showing mixed returns over the past year. This is prompting investors to reassess its longer term fundamentals and current valuation. See our latest analysis for NTT. Recent trading has been relatively subdued, with a 1-day share price return of 0.79% and a year to date share price return decline of 3.89%. The 1 year total shareholder return of 9.11%...

Why Mitsubishi (TSE:8058) is drawing fresh attention Mitsubishi (TSE:8058) has been catching investors’ eyes after a strong recent share price performance, including double digit total returns over the past year and meaningful gains over the past 3 months and month. See our latest analysis for Mitsubishi. The recent move to a ¥5,290 share price comes alongside a 29.4% 1 month share price return and a 44.8% year to date share price return, while the 1 year total shareholder return of 119.1%...

Market report puts biochar-based graphite in focus for Tokai Carbon A new Custom Market Insights report on biochar-based graphite, projecting a 13.5% CAGR from 2026 to 2035 and a market size of about US$629 million, has put Tokai Carbon (TSE:5301) on investors’ radar. See our latest analysis for Tokai Carbon. TokaI Carbon’s ¥1,113.5 share price comes after a 1-day share price return of 3.34% and a year to date share price return of 14.56%. The 1-year total shareholder return of 25.20%...

Board meeting puts potential share split and shareholder perks in focus 77 Bank (TSE:8341) has called a board meeting for February 27, 2026, to consider a share split, amendments to its Articles of Incorporation, and adjustments to its shareholder benefit program. See our latest analysis for 77 Bank. The board meeting news lands after a strong run, with a 30 day share price return of 16.28%, a 90 day share price return of 36.27%, and a 5 year total shareholder return of around 7x, suggesting...

What triggered fresh interest in Leopalace21? Leopalace21 (TSE:8848) has come into focus after releasing nine month results to December 31, 2025, alongside new earnings guidance for the fiscal year ending March 31, 2026. The company also outlined a planned JPY 30.0b term loan agreement with Mizuho Bank, intended to refinance existing debt and give investors more detail on both its income outlook and funding structure. See our latest analysis for Leopalace21. The guidance and refinancing plans...